Luigi Fernando Meneghini

Summary

Affiliation: University of Miami
Country: USA

Publications

  1. ncbi request reprint Why and how to use insulin therapy earlier in the management of type 2 diabetes
    Luigi Meneghini
    Eleanor and Joseph Kosow Diabetes Treatment Center, Diabetes Research Institute, Miami, FL 33136, USA
    South Med J 100:164-74. 2007
  2. doi request reprint Intensifying insulin therapy: what options are available to patients with type 2 diabetes?
    Luigi F Meneghini
    University of Miami Miller School of Medicine, Miami, Fla 33157, USA
    Am J Med 126:S28-37. 2013
  3. doi request reprint Once-daily initiation of basal insulin as add-on to metformin: a 26-week, randomized, treat-to-target trial comparing insulin detemir with insulin glargine in patients with type 2 diabetes
    L Meneghini
    Division of Endocrinology, Diabetes and Metabolism, University of Miami Miller School of Medicine, Miami, FL, USA
    Diabetes Obes Metab 15:729-36. 2013
  4. doi request reprint Insulin therapy for type 2 diabetes
    Luigi F Meneghini
    University of Miami Miller School of Medicine, 1450 NW 10th Ave, Miami, FL 33136, USA
    Endocrine 43:529-34. 2013
  5. pmc The efficacy and safety of insulin degludec given in variable once-daily dosing intervals compared with insulin glargine and insulin degludec dosed at the same time daily: a 26-week, randomized, open-label, parallel-group, treat-to-target trial in individ
    Luigi Meneghini
    University of Miami Miller School of Medicine, Miami, Florida, USA
    Diabetes Care 36:858-64. 2013
  6. doi request reprint Weight beneficial treatments for type 2 diabetes
    L F Meneghini
    Diabetes Research Institute, University of Miami Miller School of Medicine, 1450 N W 10th Avenue, Miami, Florida 33136, USA
    J Clin Endocrinol Metab 96:3337-53. 2011
  7. doi request reprint Comparison of 2 intensification regimens with rapid-acting insulin aspart in type 2 diabetes mellitus inadequately controlled by once-daily insulin detemir and oral antidiabetes drugs: the step-wise randomized study
    Luigi Meneghini
    Division of Endocrinology, Diabetes, and Metabolism, University of Miami Miller School of Medicine, Miami, Florida, USA
    Endocr Pract 17:727-36. 2011
  8. doi request reprint Practical aspects and considerations when switching between continuous subcutaneous insulin infusion and multiple daily injections
    Luigi Meneghini
    Division of Endocrinology and Diabetes, University of Miami Miller School of Medicine, 1450 NW 10 Avenue, Miami, FL 33136, USA
    Diabetes Technol Ther 12:S109-14. 2010
  9. doi request reprint Practical guidance to insulin management
    Luigi Meneghini
    University of Miami Miller School of Medicine, Florida 33136, USA
    Prim Care Diabetes 4:S43-56. 2010
  10. doi request reprint Improved glycemic control with insulin glargine versus pioglitazone as add-on therapy to sulfonylurea or metformin in patients with uncontrolled type 2 diabetes mellitus
    Luigi F Meneghini
    University of Miami Miller School of Medicine, Eleanor and Joseph Kosow Diabetes Treatment Center, Diabetes Research Institute, Miami, Florida 33136, USA
    Endocr Pract 16:588-99. 2010

Detail Information

Publications19

  1. ncbi request reprint Why and how to use insulin therapy earlier in the management of type 2 diabetes
    Luigi Meneghini
    Eleanor and Joseph Kosow Diabetes Treatment Center, Diabetes Research Institute, Miami, FL 33136, USA
    South Med J 100:164-74. 2007
    ..The development of insulin analogs, biphasic insulin analogs, and more convenient insulin delivery systems may make insulin therapy more manageable and help more patients achieve their treatment goals...
  2. doi request reprint Intensifying insulin therapy: what options are available to patients with type 2 diabetes?
    Luigi F Meneghini
    University of Miami Miller School of Medicine, Miami, Fla 33157, USA
    Am J Med 126:S28-37. 2013
    ..Further clinical data and approval are required before practitioners can fully endorse this novel approach. ..
  3. doi request reprint Once-daily initiation of basal insulin as add-on to metformin: a 26-week, randomized, treat-to-target trial comparing insulin detemir with insulin glargine in patients with type 2 diabetes
    L Meneghini
    Division of Endocrinology, Diabetes and Metabolism, University of Miami Miller School of Medicine, Miami, FL, USA
    Diabetes Obes Metab 15:729-36. 2013
    ..This study assessed the efficacy and safety of once-daily insulin initiation using insulin detemir (detemir) or insulin glargine (glargine) added to existing metformin in type 2 diabetes (T2D)...
  4. doi request reprint Insulin therapy for type 2 diabetes
    Luigi F Meneghini
    University of Miami Miller School of Medicine, 1450 NW 10th Ave, Miami, FL 33136, USA
    Endocrine 43:529-34. 2013
    ..Regardless of the type of insulin replacement used, the blood glucose lowering effects of insulin need to be carefully balanced with the increasing risk of hypoglycemia, and the weight gain associated with insulin intensification...
  5. pmc The efficacy and safety of insulin degludec given in variable once-daily dosing intervals compared with insulin glargine and insulin degludec dosed at the same time daily: a 26-week, randomized, open-label, parallel-group, treat-to-target trial in individ
    Luigi Meneghini
    University of Miami Miller School of Medicine, Miami, Florida, USA
    Diabetes Care 36:858-64. 2013
    ..This trial evaluated the efficacy and safety of varying the daily injection time of insulin degludec (IDeg), an ultra-long-acting basal insulin...
  6. doi request reprint Weight beneficial treatments for type 2 diabetes
    L F Meneghini
    Diabetes Research Institute, University of Miami Miller School of Medicine, 1450 N W 10th Avenue, Miami, Florida 33136, USA
    J Clin Endocrinol Metab 96:3337-53. 2011
    ..We examine the impact of "weight-friendly" type 2 diabetes pharmacotherapies and suggest treatment strategies that mitigate weight gain...
  7. doi request reprint Comparison of 2 intensification regimens with rapid-acting insulin aspart in type 2 diabetes mellitus inadequately controlled by once-daily insulin detemir and oral antidiabetes drugs: the step-wise randomized study
    Luigi Meneghini
    Division of Endocrinology, Diabetes, and Metabolism, University of Miami Miller School of Medicine, Miami, Florida, USA
    Endocr Pract 17:727-36. 2011
    ..To compare the efficacy and safety of 2 intensification strategies for stepwise addition of prandial insulin aspart in patients with type 2 diabetes mellitus treated with insulin detemir...
  8. doi request reprint Practical aspects and considerations when switching between continuous subcutaneous insulin infusion and multiple daily injections
    Luigi Meneghini
    Division of Endocrinology and Diabetes, University of Miami Miller School of Medicine, 1450 NW 10 Avenue, Miami, FL 33136, USA
    Diabetes Technol Ther 12:S109-14. 2010
    ..This article will review some of the reasons and strategies for switching from one mode of delivery to the other...
  9. doi request reprint Practical guidance to insulin management
    Luigi Meneghini
    University of Miami Miller School of Medicine, Florida 33136, USA
    Prim Care Diabetes 4:S43-56. 2010
    ....
  10. doi request reprint Improved glycemic control with insulin glargine versus pioglitazone as add-on therapy to sulfonylurea or metformin in patients with uncontrolled type 2 diabetes mellitus
    Luigi F Meneghini
    University of Miami Miller School of Medicine, Eleanor and Joseph Kosow Diabetes Treatment Center, Diabetes Research Institute, Miami, Florida 33136, USA
    Endocr Pract 16:588-99. 2010
    ..To compare glycemic control with add-on insulin glargine versus pioglitazone treatment in patients with type 2 diabetes...
  11. ncbi request reprint Once-daily insulin detemir in a cohort of insulin-naïve patients with type 2 diabetes: a sub-analysis from the PREDICTIVE study
    L F Meneghini
    University of Miami Miller School of Medicine, 1450 NW 10th Avenue, Miami, FL 33136, USA
    Curr Med Res Opin 25:1029-35. 2009
    ..This post hoc analysis evaluates insulin-naïve patients with T2DM uncontrolled on oral antidiabetic drugs (OADs) who were initiated and remained on once-daily insulin detemir for 12 weeks...
  12. doi request reprint Demonstrating strategies for initiation of insulin therapy: matching the right insulin to the right patient
    L Meneghini
    University of Miami Miller School of Medicine, Eleanor and Joseph Kosow Diabetes Treatment Center, Diabetes Research Institute, Miami, FL 33136, USA
    Int J Clin Pract 62:1255-64. 2008
    ....
  13. pmc Superior mesenteric artery syndrome in type 1 diabetes masquerading as gastroparesis
    Luigi F Meneghini
    Division of Endocrinology, Diabetes and Metabolism, Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, Florida, USA
    Diabetes Care 31:1983-4. 2008
    ..To describe and discuss a case of superior mesenteric artery syndrome (SMAS) presenting with gastrointestinal signs and symptoms mistakenly attributed to, and treated as, diabetic gastroparesis...
  14. doi request reprint Ethnic disparities in diabetes care: myth or reality?
    Luigi Meneghini
    Diabetes Research Institute, University of Miami Leonard M Miller School of Medicine, Miami, Florida 33136, USA
    Curr Opin Endocrinol Diabetes Obes 15:128-34. 2008
    ..The purpose of this review is to highlight some of the persistent gaps in the provision of healthcare, with a focus on disparities seen in vulnerable populations, as well as opportunities to address those disparities...
  15. ncbi request reprint The Avandia debacle: methodology and practical importance of the findings
    Luigi Fernando Meneghini
    Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA
    South Med J 100:1062-3. 2007
  16. ncbi request reprint The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes--results of the randomized, controlled PREDICTIVE 303 study
    L Meneghini
    Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA
    Diabetes Obes Metab 9:902-13. 2007
    ..The use of insulin detemir in this predominantly primary care setting achieved significant improvements in glycaemic control with minimal risk of hypoglycaemia and no weight gain...
  17. ncbi request reprint Impact of bariatric surgery on type 2 diabetes
    Luigi Fernando Meneghini
    Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL, USA
    Cell Biochem Biophys 48:97-102. 2007
    ..Post-prandial hyperinsulinemic hypoglycemia associated with nesidioblastosis has been described in a series of patients following gastric bypass surgery, and may be related to the described changes in GLP-1 and other gut hormones...
  18. ncbi request reprint Pharmacotherapies for diabetes management: an update for the practicing clinician
    Luigi Meneghini
    University of Miami Miller School of Medicine, Diabetes Research Institute, Miami, Florida 33136, USA
    Semin Thorac Cardiovasc Surg 18:379-89. 2006
    ....
  19. ncbi request reprint Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine: clinical practice experience from a German subgroup of the PREDICTIVE st
    L F Meneghini
    Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL 33136, USA
    Diabetes Obes Metab 9:418-27. 2007
    ....